-
Samsung Leads Global DRAM Market as SK Hynix Gains Share
-
South Korea Proposes Fourth Delay of Cryptocurrency Gains Tax to 2029
-
Kakao Details Spinoff Plan to Monetize AI Through KakaoTalk
-
ASIC Fines Mona Museum Owner's Company for Late Financial Report
-
Business Leaders Condemn Productivity Commission Inquiry for Excluding Tax and Labor Issues
-
Business Leaders Criticize Productivity Commission Inquiry Scope
-
Sheikh Hasina Vows Return to Bangladesh Despite Death Sentence
-
SCANDIC FINANCE ने एलेक्स बोडी को समूह का उपाध्यक्ष नियुक्त किया
-
SCANDIC FINANCE แต่งตั้งอเล็กซ์ โบดี เป็นรองประธานกลุ่มบริษัท
-
SCANDIC FINANCE Grubu, Alex Bodi’yi başkan yardımcılığına atadı
-
Alex Bodi wiceprezesem grupy SCANDIC FINANCE
-
Алекс Боди е назначен за вицепрезидент на групата SCANDIC FINANCE
-
Alex Bodi a SCANDIC FINANCE vállalatcsoport új alelnöke
-
Ο Άλεξ Μπόντι νέος αντιπρόεδρος του ομίλου SCANDIC FINANCE
-
Alex Bodi byl jmenován viceprezidentem skupiny SCANDIC FINANCE
-
Alex Bodi utsedd till vicepresident för SCANDIC FINANCE-koncernen
-
تعيين أليكس بودي نائبًا لرئيس مجموعة SCANDIC FINANCE
-
SCANDIC FINANCEグループ、アレックス・ボディ氏を副社長に任命
-
SCANDIC FINANCE 그룹, 알렉스 보디 부사장 선임
-
亞歷克斯・博迪獲任命為 SCANDIC FINANCE 集團副總裁
-
Алекса Боді призначено віцепрезидентом групи SCANDIC FINANCE
-
Алекс Боди назначен вице-президентом группы SCANDIC FINANCE
-
Alex Bodi appointed Vice President of SCANDIC FINANCE GROUP
-
Alex Bodi, numit vicepreședinte al grupului SCANDIC FINANCE
Czechs greenlight magic mushroom use from 2026
The outgoing Czech government said Wednesday it had approved the use of psilocybin -- the active ingredient in magic mushrooms -- for medical purposes from 2026.
Several countries have recently legalised the use by psychiatrists of the naturally occurring hallucinogenic compound, including New Zealand this year.
Lawmakers in the Czech Republic -- an EU and NATO member of 10.9 million people -- legalised the use of psilocybin in May, in an amendment to the penal code which also eased the rules for marijuana possession.
The government decision, which sets the rules for the drug's use, allows psychiatrists and psychotherapists to administer psilocybin if "treatment by registered medical substances is inefficient or if intolerance is proven".
They can only use psilocybin to treat cancer-related depression, clinically serious depression without psychotic symptoms and a worsened mental condition threatening the patient's life.
Health Minister Vlastimil Valek hailed the decision as beneficial for "the Czech health system, the expert public and patients".
In recent years, the therapeutic potential of psychedelic substances like psilocybin, as well as LSD and MDMA, has sparked renewed interest among scientists for treating depression and addiction.
New Zealand approved the use of psilocybin for depression treatment in June.
Germany allowed two clinics to use psilocybin within a "compassionate use programme", the first of its kind in the EU, in July.
Czech doctors have been allowed to prescribe medical cannabis since 2015, and cannabis treatment has been covered by public health insurance since 2020.
The centre-right Czech coalition government of right-winger Petr Fiala held its last meeting on Wednesday.
It will yield to a new coalition cabinet led by billionaire Andrej Babis, which is due to be sworn in next Monday following a general election in October.
A.P.Maia--PC